PG
LUMO

PEAK6 Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

PEAK6 Group’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-7,111
Closed -$1.17M – 4864
2016
Q1 		$1.17M Buy
+7,111
New +$1.44M 0.01% 1544

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

PEAK6 Group's LUMO Position: Q2 2016 in Review

PEAK6 Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2016, closing a stake of 7,111 shares — an estimated $1.17M sold.

PEAK6 Group first reported a position in LUMO in Q1 2016 and held it in 1 quarter. The position peaked at $1.17M in Q1 2016. 112 funds tracked by Wall St. Rank hold LUMO as of Q2 2016.

  • PEAK6 Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • PEAK6 Group sold 7,111 Lumos Pharma, Inc. Common Stock shares in Q2 2016, an estimated $1.17M.
  • PEAK6 Group first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2016 and held it in 1 quarter.
  • PEAK6 Group's Lumos Pharma, Inc. Common Stock position peaked at $1.17M in Q1 2016.
  • 112 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2016.

Based on PEAK6 Group's 13F filing for Q2 2016, filed 10 Aug 2016.